To analyze a single center's 14-year experience with 62 consecutive patients with hilar (HCCA) and peripheral (PCCA) cholangiocarcinomas.
Cholangiocarcinomas arise from the bile duct epithelium. When the disease originates in the common hepatic duct as well as in the first and second bifurcations, it can be classified as hilar-type cholangiocarcinoma (HCCA); the peripheral intrahepatic type (PCCA) takes origin in a segmental duct or more peripheral duct.'-5 Duct cell carcinomas of the common and proper bile duct6 and gallbladder were excluded from this study. Although there have been numerous reports of surgical treatment of HCCA and PCCA, long-term survival has been poor, with few exceptions. '-2 In this report, we analyze our 14-year experience. 
MATERIALS AND METHODS Patients

Preoperative Investigations
Percutaneous transhepatic cholangiography or endoscopic retrograde cholangiography, or both, were used to study the precise anatomic extension in HCCA. If indicated with HCCA, angiographic (hepatic artery, portal vein) studies were also performed. When total bilirubin exceeded 10 mg/dL, percutaneous transhepatic biliary drainage was used.10'13"4 Before resection, the diagnosis of HCCA and PCCA was confirmed by either surgery or percutaneous or endoscopic biopsy in 46% and 76% of cases, respectively.
Classification
The tumors were divided into HCCA and PCCA categories primarily by their macroscopic location and extent, as detailed in surgical pathology reports, and reviewed with available histologic material. If the classification was uncertain or ambiguous, the presence of epithelial dysplasia or carcinoma in situ was taken as an indication of origin from a major bile duct, and the tumor was designated as HCCA. 15 PCCA Thirty-two (95%) of these 34 patients survived the postoperative period. Of the 32, 24 (75%) received radiation therapy (n = 6), chemotherapy (n = 15), or both (n = 3). One patient underwent preoperative radiation therapy.
Prognostic Factors HCCA
Sex, age, tumor differentiation, vascular invasion, lymph node involvement, type of operation, presence of underlying cirrhosis, and tumor stage were analyzed (See Table 4 ). Because this tumor often involves the bifurcation of the common hepatic bile duct and usually does not form a discrete liver mass, it was impossible to determine tumor size, tumor distribution (unilobar vs. bilobar), and tumor number (single vs. multiple tumor). Adjuvant chemotherapy was not analyzable as a risk factor because >90% of the patients received some form of treatment.
PCCA
The risk influence was analyzed of sex, age, tumor size, tumor distribution, number of tumors, vascular invasion, type of treatment, tumor stage, lymph node involvement, and adjuvant treatment (See Table 4 ). Information on tumor differentiation was incomplete, and the effect of cirrhosis as a risk factor could not be analyzed because it was present in only 6% of the patients.
Statistical Analysis
The standard two-sample Student's t test was used to compare group means; Pearson's chi square test or Fisher's Exact test was used to compare proportions. The Wilcoxon rank sum test, a nonparametric equivalent to the standard two-sample Student's t test, was used for highly skewed data.
Patient survival was calculated from the date of liver resection until death, disease-free survival from the date of liver resection until the time of disease recurrence. Disease-free survival was calculated only for patients who had complete resection. Patients who were alive or disease-free as of December 1995 were censored. Disease recurrence was defined as measurable tumor by radiologic studies or by laparotomy. Survival curves were generated using the Kaplan-Meier (product-limit) method37 and were compared by the log rank (Mantel-Cox) 
RESULTS
Clinical Manifestations
HCCA
The most frequent complaint was jaundice (96%), followed by weight loss (29%), abdominal pain (20%), fever (16%), and hepatomegaly (a palpable mass) (4%).
PCCA
The most frequent complaints were abdominal pain (71%), hepatomegaly (34%), weight loss (15%), jaundice (12%), and fever (9%). One patient with PCCA had been exposed to Clonorchis sinensis. 43 Postoperative Morbidity and Mortality
HCCA
The postoperative (30-day) mortality rate was 14% (4 of 28). Complications occurred in 9 patients (32%); the most common complication was bile leak and abscess (n = 4; 19%), followed by subphrenic abscess (n = 2; 7%), liver necrosis (n = 2; 7%), and seroma (n = 1; 4% Figure 3 .
Seven patients survived 25 years (Table 5) ; only 1 of these had HCCA. Of the 6 patients with PCCA who reached this milestone (median follow-up = 89.5; range, 75.3-167.7 months), all had complete resections, single tumors, and negative lymph nodes (see Table 5 ). Five 
Disease-Free Survival
Disease-free survival was calculated for patients who underwent complete resection (see statistical analysis section). The disease-free survival rates for HCCA and PCCA were 85% (± 10%) and 77% (±9%) at 1 year; 18% (±11%) and 41% (±12%) at 3 years; and 18% (±11%) and 41% (±12%) at 5 years, respectively (Fig. 4) .
HCCA
None of the analyzed factors were statistically associated with disease-free survival. However, there was a trend for lower disease-free survival in females (p = 0.056; log rank test).
PCCA
The only factor associated with poor disease-free survival was tumor size >5 cm (p = 0.024; log rank test). 
DISCUSSION
Although the radiologic appearance of HCCA is characteristic, the preoperative pathologic diagnosis can be difficult." '45 In our study, preoperative investigations, intraoperative findings, and pathologic studies were used to distinguish HCCA from PCCA and to differentiate both varieties from tumors rising in "large" bile ducts.4'616 '20 There have been no previously reported series with this precise delineation of duct cell lesions, exclusive of those in the common and proper bile ducts.
Assessment of the extent of HCCA with preoperative studies and intraoperative findings, including the presence or absence of vascular invasion, was crucial in deciding on the optimal operation.'0'36 Treatment consisted of liver resection (including the caudate lobe) in continuity with excision of the extrahepatic bile duct all the way to the level of the pancreas and lymph node dissection.lO22-3234
During excision of HCCA, the proximal and distal bile duct, parenchyma, and vascular margins were checked with frozen sections to establish clear margins and to determine prognosis in cases where there was no possibility of further dissection. The most common postoperative complication was bile leak and abscess, followed by subphrenic abscess and liver necrosis. Bile leak and abscess was not associated with early mortality, but subphrenic abscess and liver necrosis (complications often preceded by vascular reconstruction) were responsible for three deaths.
In contrast, PCCA treatment was based primarily on liver resection, the extent of which was dictated by the location and dimensions of the tumor. Excision of the extrahepatic bile duct and lymph node dissection also were done if the malignancies were near the hilum or diffusely infiltrating. Vascular reconstruction was performed when necessary. As in the HCCA cases, the most common complication was bile leak and abscess, but only one patient died as a result of this complication.
In both HCCA and PCCA, careful attention to technical In conclusion, 5-year survival can be obtained by resection in an occasional patient with HCCA and in as many as a third of those with PCCA. New adjuvant therapies, presumably based on different principles than current ones, are clearly needed to improve these results. This is particularly true for the historically frustrating HCCA, whose strategic location so limits radical extirpation.
